IngredientsFlowering quince is botanically known as Chaenomeles speciosa (Sweet) Nakai, commonly called flowering quince or Chinese quince. It is a thorny deciduous shrub of the Rosaceae (rose) family native to eastern China. The species carries several historical synonyms: C. laganaria, Cydonia lagenaria, Cydonia speciosa, and Pyrus japonica. In traditional Chinese medicine (TCM) it is referred to as Mu Gua or, more specifically, Zhoupi Mugua (皱皮木瓜), distinguishing it from related quince species. It is also known in TCM as zhou pi mugua.
The genus Chaenomeles, a member of the Rosaceae family, consists of four species: Chaenomeles speciosa (Sweet) Nakai, Chaenomeles thibetica Yü, Chaenomeles cathayensis Schneid., and Chaenomeles japonica (Thunb.) Lindl. ex Spach., which are naturally distributed in eastern Asia. The morphological characteristics of quinces of the genera Cydonia sp., Chaenomeles sp., and Pseudocydonia sp. are largely similar, which is why these fruits are often confused.
It is a thorny deciduous shrub typically growing 1 to 3 metres tall, forming a dense, wide-spreading tangle of interlacing spiny branches. The young twigs are purplish-brown and smooth, becoming darker with age. Leaves are alternate, simple, ovate to oblong, 3 to 9 cm long, with sharply serrate margins and glossy dark green upper surfaces. The flowers come before the leaves and are usually red, but may be white or pink. The fruit can be apple or pear-shaped and up to 6.5 cm long × 6.5 cm wide. It is very harsh and acid raw but fragrant when cooked.
Chaenomeles plants are adapted to diverse ecological zones but mostly occupy the temperate areas of Korea, Japan, and China. In China, it is mainly planted in Chongqing, Anhui, and Hubei provinces, and is locally called 'Zhoupi mugua', which has been well documented in broad traditional Chinese herbal medication systems. Flowering quince is a spiny deciduous shrub in the rose family from China and Korea. This species has long been cultivated in eastern Asia for its medicinal properties, and its native habitat is somewhat obscure. Interest in the fruits has increased in recent decades due to the possibility of cultivating several species of these plants in Europe, mainly in the Baltic countries.
In mainland China, the dried fruit of Chaenomeles speciosa, known locally as "Mugua," is recorded in the Chinese Pharmacopoeia (2020) as a decoction used to disperse wind-dampness and relieve musculoskeletal pain. The Pharmacopoeia of the People's Republic of China recognizes two triterpenoid acids, namely oleanolic acid and ursolic acid, as the legal marker compounds for the drug. The same fruit appears in the Korean Herbal Pharmacopoeia (2019) as an infused tea taken for joint soreness and stiffness, while the Japanese Kampo Pharmacopoeia (2014) lists a macerated tincture of the fruit for muscle and back pain.
The fruits are harvested in summer and autumn when they are greenish-yellow. For wrinkled quince (C. speciosa), they are briefly boiled until the skin turns grayish-white, then cut in half and sun-dried. For smooth quince, they are cut into halves or quarters, quickly boiled, and then sun-dried. Both types are usually sliced and used raw in herbal preparations. Beyond decoctions, in recent decades cultivation of C. speciosa has become part of routine agriculture, fulfilling ever-increasing demands of the industry, particularly for fruit juices, fruit tea, vinegar, and fruit preservation. The fruit is also used for jams and jellies. At the research level, superfine powders, ethanolic extracts, polysaccharide fractions, and aqueous decoctions have all been used in scientific investigations.
Species of the genus Chaenomeles have been known in China for thousands of years, and their fruits are used in traditional Chinese medicine (TCM). Dried Chaenomeles fruits have been used as traditional herbal medicines since centuries within mainland China to cure dysentery, prosopalgia, rheumatoid arthritis, cholera, beriberi, vitamin C deficiency syndrome, enteritis, and hepatitis.
Chaenomeles speciosa Nakai, as a folk medicine in China for thousands of years, has been used in its dried fruit form not only for the traditional efficacy of treating dysentery, relieving dyspepsia, and alleviating enteritis, but also for eliminating dampness, calming the liver, harmonizing the stomach, and relaxing channels and activating collaterals, as well as for treating clinical conditions such as the common cold, cholera, neuralgia, rheumatoid arthritis, depression, beriberi, asthma, stroke, enteritis, hepatitis, dysentery, migraine, and vitamin C deficiency syndrome.
It has been used in TCM for thousands of years to treat a variety of diseases, including sunstroke, edema, and arthralgia. During the past decades, it has been employed to treat diarrhea and hepatitis. In addition, Chinese herbalists have used C. speciosa to treat cancer, particularly hepatocellular carcinoma.
In TCM, flowering quince fruit (known as "mu gua") is believed to have properties that "dispel wind-dampness," "harmonize the stomach," and relieve symptoms such as soreness, pain, and stiffness, which are sometimes associated with the early stages of respiratory infections like the common cold.
The dried fruits of Chaenomeles are one of the most important drugs in traditional Chinese medicine. They have been used for thousands of years to treat asthma, colds, sore throats, tuberculosis, mastitis, and hepatitis. Not only the leaves and fruits of the C. speciosa plant, but various other parts including roots, seeds, bark, twigs, and flowers all have a long history of clinical use in treating many human ailments.
For centuries, the plant was also used for the treatment of anemia, rheumatism, gout, and cardiovascular diseases. Although they have been appreciated in Asia for centuries as a valuable component of local ethnomedicine, they are less known in Western countries, and scientific knowledge about their health benefits remains fragmentary.
A series of chemical constituents, including triterpenoid, phenolic and phenylpropionic acids, flavonoids, saccharides, essential oils, and alkaloids, have been isolated from this plant, and some have already been evaluated for their biological activities. A variety of chemical constituents have been extracted from this genus, including terpenoids, phenolics, flavonoids, phenylpropanoids and their derivatives, benzoic acid derivatives, biphenyls, oxylipins, and alkaloids. In total, around 203 chemical constituents have been isolated and identified within its composition.
Various triterpenes and phenolics are present in the plant extracts, especially ursolic and oleanolic acids, which are potential chemicals recognized even in the People's Republic of China Pharmacopoeia. Many compounds, such as flavonoids (quercetin, luteolin, catechin, epicatechin, procyanidin B1 and B2), triterpenes (oleanolic acid and ursolic acid), and phenolics (gallic acid and chlorogenic acid) have been reported in C. speciosa fruits. Oleanolic acid, ursolic acid, and betulinic acid were identified as the active constituents from the fruits of Chaenomeles and might be considered as lead therapeutic agents in the treatment of LT-induced diarrhea.
Five phenolics (vanillic, gallic, chlorogenic, ferulic, and p-coumaric acids), two triterpenes (oleanolic and ursolic acids), and three flavonoids (rutin, catechin, and epicatechin) were identified and quantified by high-performance liquid chromatography-mass spectrometry (HPLC-MS) and HPLC, and antioxidant and α-glucosidase inhibitory activities of them were also evaluated. Many minor but active components such as catechin, chlorogenic acid, epicatechin, protocatechuic acid, caffeic acid, gallic acid, and syringic acid have also been extracted from C. speciosa.
As a common medicinal and edible plant, C. speciosa is rich in polysaccharides. It has been reported that polysaccharides in C. speciosa have antioxidant and anti-inflammatory activities. According to research, C. speciosa polysaccharides have significant health benefits, including anti-diabetic, anti-inflammatory and analgesic, anti-tumor, and immunomodulatory effects.
Superfine powder preparations of the fruit have been shown to be rich in antioxidants including polyphenols, saponins, oleanolic acid, ursolic acid, ascorbic acid, and superoxide dismutase (SOD). It has been reported that 100 g of Chaenomeles juice contains 124–182 mg of vitamin C, while 100 g of lemon contains rather less, typically within a range of 40–70 mg.
In correlation analyses, total phenolics, vanillic acid, catechin, ursolic acid, and oleanolic acid all contribute to DPPH radical scavenge capacity; gallic acid contributes to total ferric reducing antioxidant power; while total triterpenes, total saponins, chlorogenic acid, and ferulic acid contribute to α-glucosidase inhibitory activity.
Three compounds isolated from the ethanolic extract of C. speciosa, namely 3,4-dihydroxybenzoic acid, quercetin, and methyl-3-hydroxybutanedioic acid ester, were found to inhibit the production of TNF-α in RAW264.7 macrophage leukemia virus-transformed cells. In addition, quercetin was found to be active in the release of IL-6 with an inhibition rate of 39.8%. Studies performed on the whole ethanol extract of C. speciosa showed significant inhibition of the activity of both COX-1 and COX-2, but the extract was more than twice as active against COX-2 as against COX-1.
A study aimed to investigate the effects and underlying mechanism of polysaccharides in C. speciosa on pro-inflammatory cytokines and the MAPK pathway in complete Freund's adjuvant (CFA)-induced arthritis and LPS-induced NR8383 cells. This provides a molecular basis for the traditional use of the plant in inflammatory joint conditions.
In a study evaluating the radical scavenging capacity and activity against neuraminidase (NA) of its isolates, 3,4-dihydroxybenzoic acid displayed higher inhibitory activities on DPPH and NA with IC₅₀ values of 1.02 μg/mL and 1.27 μg/mL respectively, and quercetin also showed significant inhibitory action on DPPH and NA, with IC₅₀ values of 3.82 μg/mL and 1.90 μg/mL.
Superfine powder of C. speciosa fruit, ground by supersonic nitrogen airflow at −140°C, was investigated to assess its in vitro antioxidant activity and in vivo antiphysical fatigue activity. It was rich in antioxidants like polyphenols, saponins, oleanolic acid, ursolic acid, ascorbic acid, and SOD, and displayed promising antioxidant activity with powerful FRAP, SC-DPPH, and SC-SAR activities.
The production of uric acid (UA) is the ultimate outcome of purine metabolism. The conversion of purines into UA occurs in the liver through the action of xanthine oxidase (XOD), which has a significant impact on the production of UA by acting as a key enzyme in its synthesis. Extracts of C. speciosa have been demonstrated to inhibit this enzyme (see clinical/preclinical evidence below).
The total fruit extract increased uric acid (UA) excretion through the regulation of URAT1, GLUT9, OAT1, and OAT3 protein expression in the kidneys of hyperuricemic rats. Metabolomic analysis revealed that C. speciosa fruit modulated pathways associated with oxidative stress, including purine metabolism, arachidonic acid metabolism, and α-linolenic acid metabolism, to reverse hyperuricemia-associated metabolic disturbances.
Avian influenza is usually accompanied by virus invasion followed by the occurrence of oxidative stress and serious inflammation, and the multiple effects of the isolates may play a cocktail-like role in the treatment of avian influenza; C. speciosa components, especially quercetin, might be a potent source for anti-viral and anti-inflammatory agents. Oleanolic acid extracted from C. speciosa (20 μg/mL) robustly inhibits the replication of the hepatitis B virus genome, showing a powerful inhibition ratio of 29.33%.
Studies on C. speciosa recorded its impact on the regulation of the dopamine transporter (anti-Parkinsonian effect). According to ex vivo studies, the extract of Chaenomeles fruits shows inhibitory effects in Chinese hamster ovary cells (CHO). At the same time, the extract had no effect on the functioning of the GABA transporter and serotonin, and only a small effect on the norepinephrine transporter, suggesting the effect is specific to the dopamine transporter. The extract also had no cytotoxic effect against cells with DAT expression; its neuroprotective effect is likely caused by the prevention of the transport of toxic ligands.
Evidence strength: Preclinical (in vitro and animal models); no published human clinical trials identified in peer-reviewed literature.
C. speciosa has long been used as an herbal medicine for the treatment of various inflammatory diseases such as rheumatoid arthritis, prosopalgia, and hepatitis. Experimentally, acetic acid (HAc)-induced writhing and CFA-induced paw edema were used to determine analgesic and anti-inflammatory activity respectively. CFA rats were administered C. speciosa polysaccharides (CSP) (12.5, 25.0, and 50.0 mg/kg) daily for 3 weeks via oral gavage. The analgesic test was done using three different doses of the extract (50, 100, and 200 mg/kg). These preclinical studies demonstrate biological plausibility for the herb's traditional musculoskeletal indications, but rigorous randomized controlled trials in humans are lacking.
Evidence strength: In vitro and animal studies; no controlled human trials identified.
In in vivo rat experiments, rats supplemented with superfine C. speciosa powder had prolonged exhaustive swimming time (57%) compared to non-supplemented rats. Meanwhile, compared to the non-supplemented rats, the supplemented rats had higher levels of blood glucose and liver and muscular glycogen, and lower levels of lactic acid and blood urea nitrogen. These results are preliminary and restricted to animal models.
Evidence strength: In vitro only; no human clinical data identified.
The fruit of Chaenomeles speciosa is a traditional Chinese medicine used for the treatment of dyspepsia and various inflammatory diseases. In one study, researchers evaluated the potential radical scavenging capacity, and activity against nitrous oxide, inflammatory cytokines production, and neuraminidase (NA) of its isolates. Compounds 1, 2, and methyl-3-hydroxybutanedioic ester (3) could inhibit the production of TNF-α by 22.73%, 33.14%, and 37.19% at 5 μg/mL (P < 0.05) compared to the control. In addition, compound 2 (quercetin) was found to be active on the release of IL-6 in RAW264.7 macrophage cells, with an inhibitory rate of 39.79% (P < 0.05). These are purely cell-based findings.
Evidence strength: In vitro and mouse model studies only; no human clinical trials identified.
In a study published in oncology literature, researchers aimed to investigate the antitumor effects of Chaenomeles speciosa Nakai. The results provided the first evidence that the ethanol extract of C. speciosa (EEC) may inhibit tumor growth by directly killing tumor cells and enhancing immune function, identifying it as a natural source for safe anticancer medicine investigation. These findings are preliminary and from animal/cell models only; they do not establish clinical efficacy in cancer patients.
Evidence strength: In vitro and animal (rat model) studies; included in China's national dietary guidelines for hyperuricemia (2024). No human clinical trials identified in the peer-reviewed literature at the time of writing.
One study aimed to explore the hypouricemic effect of C. speciosa fruit extracts on hyperuricemic rats. The rats were given hypoxanthine (HX, 100 mg/kg) and potassium oxonate (PO, 300 mg/kg) for 14 days to induce hyperuricemia. Subsequently, the rats were orally administered C. speciosa fruits total extract (CSFTE, 250, 500, and 1000 mg/kg) and allopurinol (AP, 10 mg/kg) one hour after exposure to HX and PO. The results showed that CSFTE had significant xanthine oxidase (XOD) inhibitory activity in vitro (IC₅₀ value of 334.2 μg/mL) and exhibited hypouricemic effects in vivo, reducing uric acid (UA), creatinine (CRE), and blood urea nitrogen (BUN) levels in serum. CSFTE increased UA excretion through the regulation of URAT1, GLUT9, OAT1, and OAT3 protein expression in the kidneys of hyperuricemic rats. Additionally, CSFTE (500 and 1000 mg/kg) was more effective than allopurinol in improving renal injury and protecting kidney function in hyperuricemic rats.
Reflecting this preclinical promise, C. speciosa fruit has been included in China's Dietary Guidelines for Hyperuricemia and Gout in Adults (2024 Edition) as a recommended dietary supplement. However, despite its widespread consumption and preliminary evidence of efficacy, the specific bioactive compounds responsible for UA-lowering effects, their molecular targets, and the metabolic pathways they modulate in vivo remain poorly defined.
Evidence strength: In vitro enzymatic inhibition data; no human clinical trials identified.
In correlation analysis, total triterpenes, total saponins, chlorogenic acid, and ferulic acid all contribute to α-glucosidase inhibitory activity, an enzyme whose inhibition slows post-meal glucose absorption. Previous studies have confirmed that C. speciosa fruits have antioxidant and different phytochemicals for anticancer, antioxidant, antiviral, antibacterial properties, anti-inflammation, antihyperlipidemic, and antihyperglycemic activities. These effects are documented in preclinical models and cell-free assays only.
Evidence strength: Preclinical (in vitro; animal-derived cell lines); no controlled human studies identified.
Oleanolic acid extracted from C. speciosa (20 μg/mL) robustly inhibits the replication of the hepatitis B virus genome, showing a powerful inhibition ratio of 29.33%. Pharmacological investigations demonstrated that C. speciosa possesses hepatoprotective properties among other activities. No randomized controlled trials in patients with liver disease have been published.
Evidence strength: Ex vivo cell models only; no human data.
Luteolin, one of the flavonoids that can be extracted from C. speciosa, has been proven to be an anti-inflammatory and neuroprotective agent for the treatment and management of age-regulated neurodegenerative disorders. Pharmacological investigations demonstrated that C. speciosa possesses antiparkinsonian properties among other pharmacological activities. Evidence remains limited to laboratory models.
Evidence strength: Preclinical; no human trials identified.
Pharmacological investigations have revealed that this plant exhibits gastrointestinal protective activities, among other attributes. Total triterpenes from the fruits of Chaenomeles speciosa have been shown to protect against indomethacin-induced gastric mucosal injury, involving TFF1-mediated EGF/EGFR and apoptotic pathways. These mechanistic findings are preclinical.
Although Chaenomeles has been appreciated in Asia for centuries as a valuable component of local ethnomedicine, scientific knowledge about the health benefits remains fragmentary. The maximum accessible data concerning the chemical compositions and their broad pharmacological properties of C. speciosa plant parts is still quite restricted, making it an appealing subject for in-depth investigations. Research on individual TCM herbs is growing but still limited by Western clinical trial standards. In summary, all scientific evidence to date for C. speciosa is preclinical (in vitro or animal models), with no published, large-scale, placebo-controlled human clinical trials establishing therapeutic efficacy for any indication.
Based on the aggregate of traditional use and preclinical research, C. speciosa is associated with the following body systems and health areas:
The typical dosage for Mu Gua in TCM is 10–15 grams, usually prepared as a decoction (tea). The Chinese Pharmacopoeia (2020) records the dried fruit of Chaenomeles speciosa as a decoction used to disperse wind-dampness and relieve musculoskeletal pain.
No human clinical dosing regimens have been established in peer-reviewed literature; all dosages cited above are from preclinical models and cannot be directly extrapolated to human therapeutic doses.
A systematic quality control approach using thin-layer chromatography and HPLC fingerprint analysis combined with partial least-squares discrimination has been developed to reliably distinguish authentic Zhoupi Mugua (C. speciosa) from its most common adulterant, Guangpi Mugua (C. sinensis), supporting safe clinical use. Key distinguishing features: authentic Mu Gua (C. speciosa) has a deeply wrinkled, purplish-red surface when dried, while Guangpi Mugua has a smooth, reddish-brown surface with no wrinkles, a coarser granular texture, and a sandy feeling when chewed. The chemical types of the Chaenomelis Fructus samples from different regions, except for Yunnan, were basically the same; however, the relative contents of each component may vary in some of the samples.
No well-documented pharmaceutical drug interactions have been established for Mu Gua (Chaenomeles speciosa) in peer-reviewed literature. The fruit has a long history of use as both a food and medicinal ingredient across multiple East Asian cultures with no widespread reporting of serious adverse events in the ethnobotanical record.
The organic acid content of the fruit (malic acid, tartaric acid, citric acid) may theoretically affect the absorption of other substances consumed concurrently. It is very harsh and acid raw. The high acidity of raw fruit is well established and is why traditional preparations almost universally involve cooking, drying, or decoction.
Postharvest processing procedure resulted in a ≥90% reduction of insecticides. The hazard quotient (HQ) for C. speciosa decoction (with processing factors) indicated an acceptable risk for human consumption. This suggests that traditional processing substantially reduces pesticide residue burdens, though sourcing from certified, regulated suppliers is prudent.
The lack of rigorous human clinical trials means that formal safety data — including characterization of adverse events, maximum tolerated doses, reproductive safety, and pharmacokinetic parameters in humans — have not been established in the published biomedical literature. All preclinical safety signals from the available animal literature are unremarkable within the dose ranges tested, but this cannot be considered a substitute for human safety evaluation.
The vast majority of toxic Chinese herbal medicine (CHM) substances cause safety issues that are predictable. Based on thousands of years of accumulated traditional knowledge and clinical practice, the precautions, warnings, and contraindications for commonly used forms of CHM are documented in pharmacopoeias, monographs, and databases in Chinese. C. speciosa (Mu Gua) is not classified as a toxic substance in the Chinese Pharmacopoeia and carries no specific documented toxicity classification, distinguishing it from other botanicals in the Chinese materia medica that carry formal toxicity warnings.
Health conditions that Flowering quince may help support.
Flowering quince (C. speciosa) fruit is rich in polyphenols, flavonoids, quercetin, chlorogenic acid, and organic acids that demonstrate potent free-radical scavenging activity in multiple in vitro assays. Isolates such as 3,4-dihydroxybenzoic acid show IC50 values as low as 1.02 µg/mL against DPPH radicals. Polysaccharide fractions and the whole fruit extract also suppress reactive oxygen species in cell-based models. Evidence is preclinical; no human RCTs have been published.
C. speciosa has long been used in TCM for rheumatic arthralgia and is listed in the Chinese Pharmacopeia for this indication. Multiple preclinical studies confirm analgesic and anti-arthritic effects via suppression of inflammatory cytokines and the MAPK pathway. The evidence base includes several rodent arthritis models and a network pharmacology/molecular docking analysis.
Related Chaenomeles species (C. sinensis) have been studied in rodent models of diabetes, showing antihyperglycemic and antihyperlipidemic effects. C. speciosa itself is noted to have alpha-glucosidase and alpha-amylase inhibitory activity in vitro, relevant to postprandial glucose modulation. Evidence is entirely preclinical.
C. speciosa powder supplementation in mice significantly reduced serum LDL cholesterol and total cholesterol, and reduced atherosclerotic plaque area. The antihyperlipidemic effect is attributed to polyphenols and triterpenoids. Evidence is limited to animal studies.
Multiple preclinical studies demonstrate that C. speciosa extracts, fractions, and isolated constituents suppress pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) and inhibit the MAPK signaling pathway. Active constituents include polyphenols, glucosides, and triterpenoids such as oleanolic and ursolic acids. Evidence is robust at the in vitro and animal level; no clinical trials in human populations have been published.
C. speciosa has documented antinociceptive (analgesic) activity in preclinical models. Polysaccharide fractions and flavonoid-rich fractions reduced pain responses in acetic acid writhing tests and CFA-induced arthritis models. The pain-relieving mechanism may involve calcium channel modulation and suppression of pro-inflammatory mediators.
C. speciosa is documented in TCM for influenza and the common cold, and laboratory studies have identified neuraminidase (NA) inhibitory activity in isolated compounds, including quercetin and 3,4-dihydroxybenzoic acid, relevant to anti-influenza action. This anti-influenza activity is supported by in vitro mechanistic studies, though no human clinical trials exist.
C. speciosa has documented traditional use against dysentery and diarrhea in TCM for centuries, and laboratory research has begun to identify the active constituents responsible. Triterpenoids including oleanolic, ursolic, and betulinic acids were identified as active agents against E. coli heat-labile enterotoxin (LT)-induced diarrhea. The plant's astringent tannins also contribute to anti-diarrheal activity.
C. speciosa fruit triterpenoids have been evaluated for gastroprotective activity in both clinical and preclinical settings. Studies show that total triterpenoids (CSTT) reduce gastric mucosal damage, inhibit acid secretion, and modulate inflammatory cytokines. The fruit has been applied clinically in China for erosive gastritis as part of combination formulas.
Rheumatoid arthritis (RA) is specifically listed in the Chinese Pharmacopeia as an indication for dried C. speciosa fruit. The glucosides, polysaccharides, and triterpenoids of C. speciosa suppress collagen-induced arthritis in rodents and inhibit MAPK signaling, cytokine production, and synovial inflammation. One small Chinese clinical observation report exists, but RCT-level human evidence is lacking.
C. speciosa is documented in TCM texts to 'harmonize the stomach and eliminate dampness,' indicating traditional use for dyspepsia and abdominal discomfort. It has been used as a food appetizer in China and listed as a treatment for dyspepsia in TCM sources. Laboratory evidence supports gastroprotective and antispasmodic properties but direct human studies for abdominal discomfort specifically are absent.
C. speciosa is documented in TCM texts as a treatment for asthma and related respiratory complaints. The PMC 2024 review of medicinal quinces specifically notes traditional use for asthma and colds. No pharmacological studies investigating asthma-specific mechanisms or outcomes for C. speciosa have been identified.
C. speciosa is documented in TCM for enteritis, a category that includes colitis-like inflammatory bowel conditions. The fruit is listed in the Chinese Pharmacopeia and multiple pharmacological reviews for enteritis treatment. Preclinical anti-inflammatory data in gut-relevant models provides mechanistic support, though no studies specifically targeting colitis as an endpoint have been published.
Depression is listed among the traditional indications for C. speciosa in TCM texts, cited in peer-reviewed pharmacological reviews. No mechanistic or clinical studies specifically addressing depression have been identified for this plant.
Migraine (and neuralgia) are listed among the traditional therapeutic indications for C. speciosa in TCM texts and are cited in multiple peer-reviewed pharmacological reviews. No mechanistic pharmacological studies or clinical trials specifically addressing migraine have been identified.
Emesis (vomiting) is one of the four classically documented indications for C. speciosa (Mugua) in TCM, cited in multiple peer-reviewed ethnobotanical and pharmacological reviews. The anti-emetic action is attributed to the herb's antispasmodic and stomach-harmonizing properties. No clinical trials for this specific indication are documented in indexed literature.
Body systems that Flowering quince may help support.
Go back